Atlas Trials

A Study of AZD8233 in Participants With Dyslipidemia

Clinical trial NCT04641299 · COMPLETED

Trial details

NCT number
NCT04641299
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dyslipidaemia
Start date
2020-10-28
Primary completion
2021-07-20
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.